203 related articles for article (PubMed ID: 21513438)
1. Neuromodulatory effect of endogenous opioids on the intensity and unpleasantness of breathlessness during resistive load breathing in COPD.
Gifford AH; Mahler DA; Waterman LA; Ward J; Kraemer WJ; Kupchak BR; Baird JC
COPD; 2011 Jun; 8(3):160-6. PubMed ID: 21513438
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of substance P and perception of breathlessness in patients with chronic obstructive pulmonary disease.
Mahler DA; Gifford AH; Gilani A; Waterman LA; Hilton J; Chang AS; Kupchak BR; Kraemer WJ
Respir Physiol Neurobiol; 2014 Jun; 196():1-7. PubMed ID: 24582719
[TBL] [Abstract][Full Text] [Related]
3. Effect of increased blood levels of β-endorphin on perception of breathlessness.
Mahler DA; Gifford AH; Waterman LA; Ward J; Kraemer WJ; Kupchak BR; Harver A
Chest; 2013 May; 143(5):1378-1385. PubMed ID: 23715032
[TBL] [Abstract][Full Text] [Related]
4. Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD.
Mahler DA; Murray JA; Waterman LA; Ward J; Kraemer WJ; Zhang X; Baird JC
Eur Respir J; 2009 Apr; 33(4):771-7. PubMed ID: 19213787
[TBL] [Abstract][Full Text] [Related]
5. [Behavioral control of breathing and the effect of endogenous opiates in chronic obstructive pulmonary disease].
Inaba S
Hokkaido Igaku Zasshi; 1993 Jul; 68(4):477-84. PubMed ID: 8340045
[TBL] [Abstract][Full Text] [Related]
6. [Role of endogenous opioids in respiratory control system and dyspnea sensation in healthy adult humans].
Akiyama Y
Hokkaido Igaku Zasshi; 1992 Jan; 67(1):131-40. PubMed ID: 1559657
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid effects on ventilation and breathlessness: a pilot study of efficacy and safety.
Pickering EE; Semple SJ; Nazir MS; Murphy K; Snow TM; Cummin AR; Moosavi SH; Guz A; Holdcroft A
Chron Respir Dis; 2011; 8(2):109-18. PubMed ID: 21436223
[TBL] [Abstract][Full Text] [Related]
8. Naloxone does not alter response to hypercapnia or resistive loading in chronic obstructive pulmonary disease.
Simon PM; Pope A; Lahive K; Steinbrook RA; Schwartzstein RM; Weiss JW; Fencl V; Weinberger SE
Am Rev Respir Dis; 1989 Jan; 139(1):134-8. PubMed ID: 2643373
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the perception of breathlessness and inspiratory resistive loading: report on a clinical trial.
Patessio A; Rampulla C; Fracchia C; Ioli F; Majani U; De Marchi A; Donner CF
Eur Respir J Suppl; 1989 Jul; 7():587s-591s. PubMed ID: 2803413
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
[TBL] [Abstract][Full Text] [Related]
12. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
13. Endorphins and the control of breathing. Ability of naloxone to restore flow-resistive load compensation in chronic obstructive pulmonary disease.
Santiago TV; Remolina C; Scoles V; Edelman NH
N Engl J Med; 1981 May; 304(20):1190-5. PubMed ID: 6783904
[TBL] [Abstract][Full Text] [Related]
14. Endogenous pain inhibitory systems activated by spatial summation are opioid-mediated.
Julien N; Marchand S
Neurosci Lett; 2006 Jul; 401(3):256-60. PubMed ID: 16600506
[TBL] [Abstract][Full Text] [Related]
15. Inspiratory resistive loading does not increase sympathetic tone in COPD.
Raupach T; Bahr F; Herrmann P; Lüthje L; Hasenfuss G; Andreas S
Respir Med; 2010 Jan; 104(1):107-13. PubMed ID: 19619996
[TBL] [Abstract][Full Text] [Related]
16. Panic attacks and perception of inspiratory resistive loads in chronic obstructive pulmonary disease.
Livermore N; Butler JE; Sharpe L; McBain RA; Gandevia SC; McKenzie DK
Am J Respir Crit Care Med; 2008 Jul; 178(1):7-12. PubMed ID: 18436789
[TBL] [Abstract][Full Text] [Related]
17. Descriptors of dyspnea by patients with chronic obstructive pulmonary disease versus congestive heart failure.
Caroci Ade S; Lareau SC
Heart Lung; 2004; 33(2):102-10. PubMed ID: 15024375
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of a group cognitive-behavioural breathlessness intervention on health status, mood and hospital admissions in elderly patients with chronic obstructive pulmonary disease.
Howard C; Dupont S; Haselden B; Lynch J; Wills P
Psychol Health Med; 2010 Aug; 15(4):371-85. PubMed ID: 20677076
[TBL] [Abstract][Full Text] [Related]
19. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review.
Ekström M; Nilsson F; Abernethy AA; Currow DC
Ann Am Thorac Soc; 2015 Jul; 12(7):1079-92. PubMed ID: 25803110
[TBL] [Abstract][Full Text] [Related]
20. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
